DIFFUSION PHARMACEUTICALS IN (DFFN) Stock Analyst Ratings
NASDAQ:DFFN - Nasdaq - US2537484048 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 83% to DFFN. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 40.8. This target is 827.27% above the current price.
DFFN was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about DFFN.
In the previous month the buy percentage consensus was at a similar level.
DFFN was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2022-08-16 | HC Wainwright & Co. | Upgrade | Neutral -> Buy |